Larimar Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:LRMR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Feb 24	BuyUS$37,499,993	Deerfield Management Company, L.P. Series C	Company	4,290,617	US$8.74
16 Feb 24	BuyUS$499,998	Thomas Hamilton	Individual	57,208	US$8.74
14 Feb 24	BuyUS$22,000	Frank Thomas	Individual	2,000	US$11.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LRMR?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	743,373	1.14%
VC/PE Firms	10,212,180	15.6%
Hedge Funds	21,231,974	32.5%
Institutions	33,120,425	50.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.3%.

Top Shareholders

Top 25 shareholders own 94.62% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
33.3%	Deerfield Management Company, L.P. Series C	21,231,974	US$88.7m	0%	1.55%
9.47%	RA Capital Management, L.P.	6,045,351	US$25.3m	0%	0.3%
8.72%	Janus Henderson Group plc	5,566,855	US$23.3m	27.2%	0.01%
6.53%	CHI Advisors LLC	4,166,829	US$17.4m	7.96%	7.52%
6.42%	Goldman Sachs Group, Investment Banking and Securities Investments	4,096,128	US$17.1m	-3.54%	0.01%
4.66%	BlackRock, Inc.	2,972,953	US$12.4m	-5.14%	no data
3.6%	The Vanguard Group, Inc.	2,297,249	US$9.6m	-9.47%	no data
2.67%	Adage Capital Management, L.P.	1,700,877	US$7.1m	24%	0.01%
2%	Driehaus Capital Management LLC	1,279,088	US$5.3m	-2.66%	0.03%
1.95%	Woodline Partners LP	1,244,551	US$5.2m	0.16%	0.04%
1.82%	Verition Fund Management LLC	1,161,750	US$4.9m	-27.1%	0.04%
1.43%	State Street Global Advisors, Inc.	914,318	US$3.8m	-0.21%	no data
1.41%	Geode Capital Management, LLC	901,262	US$3.8m	-20.9%	no data
1.34%	Mangrove Partners IM, LLC	855,815	US$3.6m	0%	0.35%
1.23%	Fred Alger Management, LLC	786,588	US$3.3m	-15.7%	0.01%
1.2%	Millennium Management LLC	763,859	US$3.2m	-25%	no data
1.11%	Alyeska Investment Group, L.P.	710,157	US$3.0m	-13.6%	0.01%
1.09%	Altium Capital Management LP	693,000	US$2.9m	0%	0.87%
0.89%	Thomas Hamilton	564,798	US$2.4m	0%	no data
0.83%	FMR LLC	526,750	US$2.2m	0.2%	no data
0.77%	Dafna Capital Management, LLC	494,274	US$2.1m	-22.8%	0.53%
0.65%	Sphera Funds Management Ltd	414,478	US$1.7m	32.7%	0.28%
0.55%	Renaissance Technologies LLC	353,842	US$1.5m	27.1%	no data
0.54%	Northern Trust Global Investments	346,534	US$1.4m	15.9%	no data
0.44%	Deutsche Asset & Wealth Management	282,062	US$1.2m	2.73%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/05 13:45
End of Day Share Price	2025/01/03 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Larimar Therapeutics, Inc. is covered by 13 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Joel Beatty	Baird
Samantha Lynn Semenkow	Citigroup Inc
Samantha Lynn Semenkow	Citigroup Inc